nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—ABCC2—Vincristine—sarcoma	0.138	0.208	CbGbCtD
Spironolactone—ABCC2—Etoposide—sarcoma	0.126	0.19	CbGbCtD
Spironolactone—ABCC2—Doxorubicin—sarcoma	0.0861	0.13	CbGbCtD
Spironolactone—ABCB1—Dactinomycin—sarcoma	0.0729	0.11	CbGbCtD
Spironolactone—ABCB1—Mitoxantrone—sarcoma	0.0652	0.0984	CbGbCtD
Spironolactone—CYP2C8—Etoposide—sarcoma	0.0608	0.0917	CbGbCtD
Spironolactone—ABCB1—Vincristine—sarcoma	0.0449	0.0677	CbGbCtD
Spironolactone—ABCB1—Etoposide—sarcoma	0.0411	0.062	CbGbCtD
Spironolactone—ABCB1—Doxorubicin—sarcoma	0.0281	0.0423	CbGbCtD
Spironolactone—AR—scrotum—sarcoma	0.0204	0.141	CbGeAlD
Spironolactone—SHBG—hindlimb—sarcoma	0.0097	0.0667	CbGeAlD
Spironolactone—CYP11B2—hematopoietic system—sarcoma	0.00542	0.0373	CbGeAlD
Spironolactone—CYP11B1—hematopoietic system—sarcoma	0.00542	0.0373	CbGeAlD
Spironolactone—PGR—mammary gland—sarcoma	0.00365	0.0251	CbGeAlD
Spironolactone—SHBG—Nongenotropic Androgen signaling—PLCG1—sarcoma	0.00349	0.071	CbGpPWpGaD
Spironolactone—Amenorrhoea—Thiotepa—sarcoma	0.00293	0.0206	CcSEcCtD
Spironolactone—NR3C2—myometrium—sarcoma	0.00279	0.0192	CbGeAlD
Spironolactone—Ulcer—Dactinomycin—sarcoma	0.0027	0.019	CcSEcCtD
Spironolactone—PGR—Ovarian Infertility Genes—GJA4—sarcoma	0.00269	0.0547	CbGpPWpGaD
Spironolactone—PGR—myometrium—sarcoma	0.00259	0.0178	CbGeAlD
Spironolactone—Amenorrhoea—Mitoxantrone—sarcoma	0.00253	0.0178	CcSEcCtD
Spironolactone—NR3C2—seminal vesicle—sarcoma	0.00252	0.0173	CbGeAlD
Spironolactone—SHBG—hematopoietic system—sarcoma	0.00247	0.017	CbGeAlD
Spironolactone—NR3C2—hematopoietic system—sarcoma	0.00239	0.0164	CbGeAlD
Spironolactone—SHBG—connective tissue—sarcoma	0.00238	0.0163	CbGeAlD
Spironolactone—Ulcer—Mitoxantrone—sarcoma	0.00235	0.0165	CcSEcCtD
Spironolactone—CYP2C8—mammary gland—sarcoma	0.00235	0.0162	CbGeAlD
Spironolactone—NR3C2—connective tissue—sarcoma	0.0023	0.0158	CbGeAlD
Spironolactone—PGR—hematopoietic system—sarcoma	0.00222	0.0153	CbGeAlD
Spironolactone—Hyperkalaemia—Mitoxantrone—sarcoma	0.00218	0.0154	CcSEcCtD
Spironolactone—CYP11B2—lymph node—sarcoma	0.00215	0.0148	CbGeAlD
Spironolactone—PGR—connective tissue—sarcoma	0.00214	0.0147	CbGeAlD
Spironolactone—NR3C2—smooth muscle tissue—sarcoma	0.00211	0.0145	CbGeAlD
Spironolactone—AR—myometrium—sarcoma	0.00206	0.0142	CbGeAlD
Spironolactone—SLCO1A2—hematopoietic system—sarcoma	0.00205	0.0141	CbGeAlD
Spironolactone—PGR—smooth muscle tissue—sarcoma	0.00196	0.0135	CbGeAlD
Spironolactone—Ulcer—Etoposide—sarcoma	0.00196	0.0137	CcSEcCtD
Spironolactone—Lethargy—Dactinomycin—sarcoma	0.00189	0.0133	CcSEcCtD
Spironolactone—SHBG—uterus—sarcoma	0.00186	0.0128	CbGeAlD
Spironolactone—AR—seminal vesicle—sarcoma	0.00186	0.0128	CbGeAlD
Spironolactone—NR3C2—cardiac atrium—sarcoma	0.00182	0.0125	CbGeAlD
Spironolactone—NR3C2—uterus—sarcoma	0.00181	0.0124	CbGeAlD
Spironolactone—SHBG—Nongenotropic Androgen signaling—CREB1—sarcoma	0.0018	0.0365	CbGpPWpGaD
Spironolactone—AR—hematopoietic system—sarcoma	0.00177	0.0122	CbGeAlD
Spironolactone—Ataxia—Thiotepa—sarcoma	0.00176	0.0124	CcSEcCtD
Spironolactone—Renal failure acute—Mitoxantrone—sarcoma	0.00175	0.0123	CcSEcCtD
Spironolactone—AR—connective tissue—sarcoma	0.00171	0.0117	CbGeAlD
Spironolactone—PGR—uterus—sarcoma	0.00168	0.0115	CbGeAlD
Spironolactone—Toxic epidermal necrolysis—Dactinomycin—sarcoma	0.00167	0.0117	CcSEcCtD
Spironolactone—NR3C2—tendon—sarcoma	0.00158	0.0109	CbGeAlD
Spironolactone—SHBG—bone marrow—sarcoma	0.00158	0.0109	CbGeAlD
Spironolactone—PGR—lymphoid tissue—sarcoma	0.00157	0.0108	CbGeAlD
Spironolactone—AR—smooth muscle tissue—sarcoma	0.00156	0.0107	CbGeAlD
Spironolactone—Ataxia—Vincristine—sarcoma	0.00156	0.011	CcSEcCtD
Spironolactone—AR—skin of body—sarcoma	0.00154	0.0106	CbGeAlD
Spironolactone—NR3C1—myometrium—sarcoma	0.00149	0.0103	CbGeAlD
Spironolactone—NR3C1—embryo—sarcoma	0.00144	0.00988	CbGeAlD
Spironolactone—CYP2C8—hematopoietic system—sarcoma	0.00143	0.00985	CbGeAlD
Spironolactone—Stevens-Johnson syndrome—Dactinomycin—sarcoma	0.00142	0.00996	CcSEcCtD
Spironolactone—Renal failure—Thiotepa—sarcoma	0.00142	0.00995	CcSEcCtD
Spironolactone—AR—FOXA1 transcription factor network—COL18A1—sarcoma	0.00137	0.0279	CbGpPWpGaD
Spironolactone—Rash erythematous—Epirubicin—sarcoma	0.00135	0.00952	CcSEcCtD
Spironolactone—SHBG—testis—sarcoma	0.00135	0.0093	CbGeAlD
Spironolactone—NR3C1—seminal vesicle—sarcoma	0.00135	0.00928	CbGeAlD
Spironolactone—AR—cardiac atrium—sarcoma	0.00134	0.00925	CbGeAlD
Spironolactone—Agranulocytosis—Thiotepa—sarcoma	0.00134	0.00945	CcSEcCtD
Spironolactone—AR—uterus—sarcoma	0.00134	0.0092	CbGeAlD
Spironolactone—PGR—Validated nuclear estrogen receptor alpha network—COL18A1—sarcoma	0.00133	0.0271	CbGpPWpGaD
Spironolactone—Agranulocytosis—Dactinomycin—sarcoma	0.00133	0.00938	CcSEcCtD
Spironolactone—Erectile dysfunction—Vincristine—sarcoma	0.00132	0.00928	CcSEcCtD
Spironolactone—NR3C2—testis—sarcoma	0.00131	0.00901	CbGeAlD
Spironolactone—Erectile dysfunction—Mitoxantrone—sarcoma	0.00128	0.00903	CcSEcCtD
Spironolactone—NR3C1—hematopoietic system—sarcoma	0.00128	0.00882	CbGeAlD
Spironolactone—SHBG—liver—sarcoma	0.00128	0.00879	CbGeAlD
Spironolactone—ABCC2—tendon—sarcoma	0.00126	0.00869	CbGeAlD
Spironolactone—Rash erythematous—Doxorubicin—sarcoma	0.00125	0.00881	CcSEcCtD
Spironolactone—AR—lymphoid tissue—sarcoma	0.00125	0.00857	CbGeAlD
Spironolactone—Drowsiness—Mitoxantrone—sarcoma	0.00124	0.00875	CcSEcCtD
Spironolactone—NR3C2—liver—sarcoma	0.00124	0.00852	CbGeAlD
Spironolactone—NR3C1—connective tissue—sarcoma	0.00124	0.00849	CbGeAlD
Spironolactone—Renal failure—Mitoxantrone—sarcoma	0.00122	0.0086	CcSEcCtD
Spironolactone—PGR—testis—sarcoma	0.00122	0.00838	CbGeAlD
Spironolactone—Erythema multiforme—Dactinomycin—sarcoma	0.00121	0.00853	CcSEcCtD
Spironolactone—Cramp muscle—Etoposide—sarcoma	0.00121	0.0085	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Etoposide—sarcoma	0.00121	0.0085	CcSEcCtD
Spironolactone—Breast pain—Epirubicin—sarcoma	0.00119	0.00835	CcSEcCtD
Spironolactone—Amenorrhoea—Epirubicin—sarcoma	0.00118	0.0083	CcSEcCtD
Spironolactone—AR—tendon—sarcoma	0.00117	0.00806	CbGeAlD
Spironolactone—AR—Notch-mediated HES/HEY network—TLE1—sarcoma	0.00117	0.0238	CbGpPWpGaD
Spironolactone—Agranulocytosis—Mitoxantrone—sarcoma	0.00116	0.00816	CcSEcCtD
Spironolactone—SHBG—Nongenotropic Androgen signaling—SRC—sarcoma	0.00116	0.0236	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYOG—sarcoma	0.00116	0.0236	CbGpPWpGaD
Spironolactone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—ATF1—sarcoma	0.00115	0.0234	CbGpPWpGaD
Spironolactone—Alopecia—Thiotepa—sarcoma	0.00114	0.00803	CcSEcCtD
Spironolactone—Alopecia—Dactinomycin—sarcoma	0.00113	0.00797	CcSEcCtD
Spironolactone—NR3C1—smooth muscle tissue—sarcoma	0.00113	0.00777	CbGeAlD
Spironolactone—SLCO1A2—testis—sarcoma	0.00112	0.00772	CbGeAlD
Spironolactone—NR3C1—skin of body—sarcoma	0.00112	0.00767	CbGeAlD
Spironolactone—Breast pain—Doxorubicin—sarcoma	0.0011	0.00773	CcSEcCtD
Spironolactone—Ulcer—Epirubicin—sarcoma	0.0011	0.00771	CcSEcCtD
Spironolactone—AR—Notch-mediated HES/HEY network—MYOD1—sarcoma	0.0011	0.0223	CbGpPWpGaD
Spironolactone—Amenorrhoea—Doxorubicin—sarcoma	0.00109	0.00768	CcSEcCtD
Spironolactone—AR—Nongenotropic Androgen signaling—PLCG1—sarcoma	0.00108	0.022	CbGpPWpGaD
Spironolactone—SLCO1A2—liver—sarcoma	0.00106	0.0073	CbGeAlD
Spironolactone—ABCC2—testis—sarcoma	0.00105	0.0072	CbGeAlD
Spironolactone—Ill-defined disorder—Dactinomycin—sarcoma	0.00104	0.00729	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Etoposide—sarcoma	0.00103	0.00721	CcSEcCtD
Spironolactone—Hyperkalaemia—Epirubicin—sarcoma	0.00102	0.00716	CcSEcCtD
Spironolactone—Renal failure—Etoposide—sarcoma	0.00102	0.00715	CcSEcCtD
Spironolactone—Ulcer—Doxorubicin—sarcoma	0.00101	0.00713	CcSEcCtD
Spironolactone—Alopecia—Vincristine—sarcoma	0.00101	0.00712	CcSEcCtD
Spironolactone—Leukopenia—Thiotepa—sarcoma	0.00101	0.00708	CcSEcCtD
Spironolactone—Malaise—Dactinomycin—sarcoma	0.00101	0.00708	CcSEcCtD
Spironolactone—Leukopenia—Dactinomycin—sarcoma	0.001	0.00703	CcSEcCtD
Spironolactone—ABCC2—liver—sarcoma	0.000989	0.0068	CbGeAlD
Spironolactone—Alopecia—Mitoxantrone—sarcoma	0.000987	0.00694	CcSEcCtD
Spironolactone—NR3C1—cardiac atrium—sarcoma	0.000974	0.0067	CbGeAlD
Spironolactone—AR—testis—sarcoma	0.000971	0.00667	CbGeAlD
Spironolactone—NR3C1—uterus—sarcoma	0.000969	0.00666	CbGeAlD
Spironolactone—Agranulocytosis—Etoposide—sarcoma	0.000966	0.00679	CcSEcCtD
Spironolactone—Cramps of lower extremities—Epirubicin—sarcoma	0.000953	0.0067	CcSEcCtD
Spironolactone—NR3C2—lymph node—sarcoma	0.00095	0.00653	CbGeAlD
Spironolactone—Hyperkalaemia—Doxorubicin—sarcoma	0.000943	0.00663	CcSEcCtD
Spironolactone—Discomfort—Dactinomycin—sarcoma	0.00094	0.00661	CcSEcCtD
Spironolactone—Confusional state—Thiotepa—sarcoma	0.000926	0.00651	CcSEcCtD
Spironolactone—AR—liver—sarcoma	0.000918	0.00631	CbGeAlD
Spironolactone—NR3C1—lymphoid tissue—sarcoma	0.000903	0.00621	CbGeAlD
Spironolactone—Ill-defined disorder—Mitoxantrone—sarcoma	0.000902	0.00634	CcSEcCtD
Spironolactone—Thrombocytopenia—Thiotepa—sarcoma	0.0009	0.00632	CcSEcCtD
Spironolactone—Leukopenia—Vincristine—sarcoma	0.000894	0.00628	CcSEcCtD
Spironolactone—Thrombocytopenia—Dactinomycin—sarcoma	0.000893	0.00628	CcSEcCtD
Spironolactone—PGR—lymph node—sarcoma	0.000883	0.00607	CbGeAlD
Spironolactone—Cramps of lower extremities—Doxorubicin—sarcoma	0.000881	0.0062	CcSEcCtD
Spironolactone—Erythema multiforme—Etoposide—sarcoma	0.000878	0.00617	CcSEcCtD
Spironolactone—Malaise—Mitoxantrone—sarcoma	0.000877	0.00616	CcSEcCtD
Spironolactone—Leukopenia—Mitoxantrone—sarcoma	0.00087	0.00612	CcSEcCtD
Spironolactone—NR3C1—tendon—sarcoma	0.000849	0.00584	CbGeAlD
Spironolactone—NR3C1—bone marrow—sarcoma	0.000822	0.00565	CbGeAlD
Spironolactone—Alopecia—Etoposide—sarcoma	0.000821	0.00577	CcSEcCtD
Spironolactone—Discomfort—Mitoxantrone—sarcoma	0.000818	0.00575	CcSEcCtD
Spironolactone—Somnolence—Thiotepa—sarcoma	0.000817	0.00574	CcSEcCtD
Spironolactone—SHBG—Nongenotropic Androgen signaling—HRAS—sarcoma	0.000816	0.0166	CbGpPWpGaD
Spironolactone—Renal failure acute—Epirubicin—sarcoma	0.000815	0.00573	CcSEcCtD
Spironolactone—Anaphylactic shock—Vincristine—sarcoma	0.000815	0.00573	CcSEcCtD
Spironolactone—Confusional state—Mitoxantrone—sarcoma	0.0008	0.00562	CcSEcCtD
Spironolactone—ABCB1—myometrium—sarcoma	0.0008	0.0055	CbGeAlD
Spironolactone—Thrombocytopenia—Vincristine—sarcoma	0.000798	0.00561	CcSEcCtD
Spironolactone—Anaphylactic shock—Mitoxantrone—sarcoma	0.000793	0.00558	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Thiotepa—sarcoma	0.000793	0.00558	CcSEcCtD
Spironolactone—CYP2C8—testis—sarcoma	0.000785	0.0054	CbGeAlD
Spironolactone—Muscle spasms—Etoposide—sarcoma	0.000777	0.00547	CcSEcCtD
Spironolactone—Thrombocytopenia—Mitoxantrone—sarcoma	0.000777	0.00546	CcSEcCtD
Spironolactone—ABCB1—embryo—sarcoma	0.000769	0.00529	CbGeAlD
Spironolactone—Lethargy—Epirubicin—sarcoma	0.000768	0.0054	CcSEcCtD
Spironolactone—NR3C1—Transcription factor regulation in adipogenesis—FOXO1—sarcoma	0.000766	0.0156	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TLE1—sarcoma	0.000764	0.0155	CbGpPWpGaD
Spironolactone—ABCC2—lymph node—sarcoma	0.000759	0.00522	CbGeAlD
Spironolactone—Feeling abnormal—Thiotepa—sarcoma	0.000757	0.00532	CcSEcCtD
Spironolactone—Renal failure acute—Doxorubicin—sarcoma	0.000754	0.0053	CcSEcCtD
Spironolactone—Feeling abnormal—Dactinomycin—sarcoma	0.000751	0.00528	CcSEcCtD
Spironolactone—Ill-defined disorder—Etoposide—sarcoma	0.00075	0.00527	CcSEcCtD
Spironolactone—CYP2C8—liver—sarcoma	0.000742	0.0051	CbGeAlD
Spironolactone—Urticaria—Thiotepa—sarcoma	0.00073	0.00513	CcSEcCtD
Spironolactone—Malaise—Etoposide—sarcoma	0.000729	0.00513	CcSEcCtD
Spironolactone—Body temperature increased—Thiotepa—sarcoma	0.000726	0.00511	CcSEcCtD
Spironolactone—Leukopenia—Etoposide—sarcoma	0.000724	0.00509	CcSEcCtD
Spironolactone—ABCB1—seminal vesicle—sarcoma	0.000723	0.00497	CbGeAlD
Spironolactone—Body temperature increased—Dactinomycin—sarcoma	0.000721	0.00507	CcSEcCtD
Spironolactone—Lethargy—Doxorubicin—sarcoma	0.000711	0.005	CcSEcCtD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—MYOD1—sarcoma	0.000709	0.0144	CbGpPWpGaD
Spironolactone—Ataxia—Epirubicin—sarcoma	0.000708	0.00498	CcSEcCtD
Spironolactone—Somnolence—Mitoxantrone—sarcoma	0.000705	0.00496	CcSEcCtD
Spironolactone—AR—lymph node—sarcoma	0.000704	0.00484	CbGeAlD
Spironolactone—Gastrointestinal disorder—Vincristine—sarcoma	0.000703	0.00494	CcSEcCtD
Spironolactone—NR3C1—testis—sarcoma	0.000703	0.00483	CbGeAlD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—PLCG1—sarcoma	0.000688	0.014	CbGpPWpGaD
Spironolactone—ABCB1—hematopoietic system—sarcoma	0.000687	0.00472	CbGeAlD
Spironolactone—Discomfort—Etoposide—sarcoma	0.00068	0.00478	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000678	0.00476	CcSEcCtD
Spironolactone—Hypersensitivity—Thiotepa—sarcoma	0.000677	0.00476	CcSEcCtD
Spironolactone—Hypersensitivity—Dactinomycin—sarcoma	0.000672	0.00472	CcSEcCtD
Spironolactone—Gastritis—Epirubicin—sarcoma	0.000666	0.00468	CcSEcCtD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MITF—sarcoma	0.000666	0.0135	CbGpPWpGaD
Spironolactone—Confusional state—Etoposide—sarcoma	0.000665	0.00468	CcSEcCtD
Spironolactone—NR3C1—liver—sarcoma	0.000665	0.00457	CbGeAlD
Spironolactone—Anaphylactic shock—Etoposide—sarcoma	0.00066	0.00464	CcSEcCtD
Spironolactone—Ataxia—Doxorubicin—sarcoma	0.000655	0.0046	CcSEcCtD
Spironolactone—Feeling abnormal—Mitoxantrone—sarcoma	0.000654	0.0046	CcSEcCtD
Spironolactone—Pruritus—Thiotepa—sarcoma	0.00065	0.00457	CcSEcCtD
Spironolactone—ABCC2—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000648	0.0132	CbGpPWpGaD
Spironolactone—Thrombocytopenia—Etoposide—sarcoma	0.000646	0.00454	CcSEcCtD
Spironolactone—Eosinophilia—Epirubicin—sarcoma	0.000644	0.00453	CcSEcCtD
Spironolactone—Body temperature increased—Vincristine—sarcoma	0.000644	0.00453	CcSEcCtD
Spironolactone—Urticaria—Mitoxantrone—sarcoma	0.00063	0.00443	CcSEcCtD
Spironolactone—Diarrhoea—Thiotepa—sarcoma	0.000629	0.00442	CcSEcCtD
Spironolactone—Body temperature increased—Mitoxantrone—sarcoma	0.000627	0.00441	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000627	0.00441	CcSEcCtD
Spironolactone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—CREB1—sarcoma	0.000625	0.0127	CbGpPWpGaD
Spironolactone—Diarrhoea—Dactinomycin—sarcoma	0.000624	0.00439	CcSEcCtD
Spironolactone—Gastritis—Doxorubicin—sarcoma	0.000616	0.00433	CcSEcCtD
Spironolactone—Dizziness—Thiotepa—sarcoma	0.000608	0.00427	CcSEcCtD
Spironolactone—Hypersensitivity—Vincristine—sarcoma	0.0006	0.00422	CcSEcCtD
Spironolactone—Eosinophilia—Doxorubicin—sarcoma	0.000596	0.00419	CcSEcCtD
Spironolactone—Somnolence—Etoposide—sarcoma	0.000587	0.00412	CcSEcCtD
Spironolactone—Hypersensitivity—Mitoxantrone—sarcoma	0.000585	0.00411	CcSEcCtD
Spironolactone—Vomiting—Thiotepa—sarcoma	0.000584	0.00411	CcSEcCtD
Spironolactone—Drowsiness—Epirubicin—sarcoma	0.00058	0.00408	CcSEcCtD
Spironolactone—Vomiting—Dactinomycin—sarcoma	0.00058	0.00408	CcSEcCtD
Spironolactone—Rash—Thiotepa—sarcoma	0.000579	0.00407	CcSEcCtD
Spironolactone—Dermatitis—Thiotepa—sarcoma	0.000579	0.00407	CcSEcCtD
Spironolactone—Headache—Thiotepa—sarcoma	0.000576	0.00405	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000575	0.00404	CcSEcCtD
Spironolactone—Rash—Dactinomycin—sarcoma	0.000575	0.00404	CcSEcCtD
Spironolactone—Renal failure—Epirubicin—sarcoma	0.00057	0.00401	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Etoposide—sarcoma	0.00057	0.00401	CcSEcCtD
Spironolactone—Diarrhoea—Vincristine—sarcoma	0.000557	0.00392	CcSEcCtD
Spironolactone—AR—Nongenotropic Androgen signaling—CREB1—sarcoma	0.000557	0.0113	CbGpPWpGaD
Spironolactone—NR3C1—Transcription factor regulation in adipogenesis—CREB1—sarcoma	0.000556	0.0113	CbGpPWpGaD
Spironolactone—Nausea—Thiotepa—sarcoma	0.000546	0.00384	CcSEcCtD
Spironolactone—Feeling abnormal—Etoposide—sarcoma	0.000544	0.00382	CcSEcCtD
Spironolactone—Diarrhoea—Mitoxantrone—sarcoma	0.000543	0.00382	CcSEcCtD
Spironolactone—Nausea—Dactinomycin—sarcoma	0.000542	0.00381	CcSEcCtD
Spironolactone—Agranulocytosis—Epirubicin—sarcoma	0.000541	0.00381	CcSEcCtD
Spironolactone—Dizziness—Vincristine—sarcoma	0.000539	0.00379	CcSEcCtD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYOD1—sarcoma	0.000538	0.0109	CbGpPWpGaD
Spironolactone—Drowsiness—Doxorubicin—sarcoma	0.000537	0.00377	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000532	0.00374	CcSEcCtD
Spironolactone—Renal failure—Doxorubicin—sarcoma	0.000528	0.00371	CcSEcCtD
Spironolactone—Urticaria—Etoposide—sarcoma	0.000524	0.00369	CcSEcCtD
Spironolactone—Body temperature increased—Etoposide—sarcoma	0.000522	0.00367	CcSEcCtD
Spironolactone—ABCB1—uterus—sarcoma	0.000519	0.00357	CbGeAlD
Spironolactone—Vomiting—Vincristine—sarcoma	0.000518	0.00364	CcSEcCtD
Spironolactone—Rash—Vincristine—sarcoma	0.000514	0.00361	CcSEcCtD
Spironolactone—Dermatitis—Vincristine—sarcoma	0.000513	0.00361	CcSEcCtD
Spironolactone—Headache—Vincristine—sarcoma	0.00051	0.00359	CcSEcCtD
Spironolactone—NR3C1—lymph node—sarcoma	0.00051	0.0035	CbGeAlD
Spironolactone—Vomiting—Mitoxantrone—sarcoma	0.000504	0.00355	CcSEcCtD
Spironolactone—Agranulocytosis—Doxorubicin—sarcoma	0.000501	0.00352	CcSEcCtD
Spironolactone—Rash—Mitoxantrone—sarcoma	0.0005	0.00352	CcSEcCtD
Spironolactone—Dermatitis—Mitoxantrone—sarcoma	0.0005	0.00351	CcSEcCtD
Spironolactone—AR—Regulation of Androgen receptor activity—FOXO1—sarcoma	0.0005	0.0102	CbGpPWpGaD
Spironolactone—Headache—Mitoxantrone—sarcoma	0.000497	0.00349	CcSEcCtD
Spironolactone—Erythema multiforme—Epirubicin—sarcoma	0.000492	0.00346	CcSEcCtD
Spironolactone—Hypersensitivity—Etoposide—sarcoma	0.000486	0.00342	CcSEcCtD
Spironolactone—Nausea—Vincristine—sarcoma	0.000484	0.0034	CcSEcCtD
Spironolactone—ABCB1—lymphoid tissue—sarcoma	0.000483	0.00332	CbGeAlD
Spironolactone—Nausea—Mitoxantrone—sarcoma	0.000471	0.00331	CcSEcCtD
Spironolactone—Pruritus—Etoposide—sarcoma	0.000467	0.00328	CcSEcCtD
Spironolactone—Alopecia—Epirubicin—sarcoma	0.00046	0.00323	CcSEcCtD
Spironolactone—Erythema multiforme—Doxorubicin—sarcoma	0.000456	0.0032	CcSEcCtD
Spironolactone—AR—Notch-mediated HES/HEY network—KDR—sarcoma	0.000455	0.00925	CbGpPWpGaD
Spironolactone—Diarrhoea—Etoposide—sarcoma	0.000452	0.00317	CcSEcCtD
Spironolactone—ABCB1—bone marrow—sarcoma	0.00044	0.00303	CbGeAlD
Spironolactone—Dizziness—Etoposide—sarcoma	0.000436	0.00307	CcSEcCtD
Spironolactone—Muscle spasms—Epirubicin—sarcoma	0.000436	0.00306	CcSEcCtD
Spironolactone—Alopecia—Doxorubicin—sarcoma	0.000426	0.00299	CcSEcCtD
Spironolactone—Ill-defined disorder—Epirubicin—sarcoma	0.000421	0.00296	CcSEcCtD
Spironolactone—Vomiting—Etoposide—sarcoma	0.00042	0.00295	CcSEcCtD
Spironolactone—Rash—Etoposide—sarcoma	0.000416	0.00293	CcSEcCtD
Spironolactone—Dermatitis—Etoposide—sarcoma	0.000416	0.00292	CcSEcCtD
Spironolactone—Headache—Etoposide—sarcoma	0.000413	0.00291	CcSEcCtD
Spironolactone—Malaise—Epirubicin—sarcoma	0.000409	0.00287	CcSEcCtD
Spironolactone—Leukopenia—Epirubicin—sarcoma	0.000406	0.00285	CcSEcCtD
Spironolactone—Muscle spasms—Doxorubicin—sarcoma	0.000403	0.00283	CcSEcCtD
Spironolactone—Nausea—Etoposide—sarcoma	0.000392	0.00276	CcSEcCtD
Spironolactone—Ill-defined disorder—Doxorubicin—sarcoma	0.000389	0.00274	CcSEcCtD
Spironolactone—Discomfort—Epirubicin—sarcoma	0.000381	0.00268	CcSEcCtD
Spironolactone—NR3C1—Regulation of Androgen receptor activity—FOXO1—sarcoma	0.000379	0.0077	CbGpPWpGaD
Spironolactone—Malaise—Doxorubicin—sarcoma	0.000378	0.00266	CcSEcCtD
Spironolactone—ABCB1—testis—sarcoma	0.000376	0.00259	CbGeAlD
Spironolactone—Leukopenia—Doxorubicin—sarcoma	0.000375	0.00264	CcSEcCtD
Spironolactone—Confusional state—Epirubicin—sarcoma	0.000373	0.00262	CcSEcCtD
Spironolactone—Anaphylactic shock—Epirubicin—sarcoma	0.00037	0.0026	CcSEcCtD
Spironolactone—Thrombocytopenia—Epirubicin—sarcoma	0.000362	0.00255	CcSEcCtD
Spironolactone—AR—Nongenotropic Androgen signaling—SRC—sarcoma	0.000359	0.0073	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—FOXO1—sarcoma	0.000356	0.00723	CbGpPWpGaD
Spironolactone—ABCB1—liver—sarcoma	0.000356	0.00245	CbGeAlD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—CREB1—sarcoma	0.000354	0.00719	CbGpPWpGaD
Spironolactone—Discomfort—Doxorubicin—sarcoma	0.000353	0.00248	CcSEcCtD
Spironolactone—Confusional state—Doxorubicin—sarcoma	0.000345	0.00243	CcSEcCtD
Spironolactone—Anaphylactic shock—Doxorubicin—sarcoma	0.000342	0.00241	CcSEcCtD
Spironolactone—Thrombocytopenia—Doxorubicin—sarcoma	0.000335	0.00236	CcSEcCtD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.000332	0.00674	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—FOXO1—sarcoma	0.00033	0.00671	CbGpPWpGaD
Spironolactone—Somnolence—Epirubicin—sarcoma	0.000329	0.00231	CcSEcCtD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—NPM1—sarcoma	0.000328	0.00666	CbGpPWpGaD
Spironolactone—Gastrointestinal disorder—Epirubicin—sarcoma	0.000319	0.00225	CcSEcCtD
Spironolactone—NR3C1—FOXA2 and FOXA3 transcription factor networks—CREB1—sarcoma	0.000319	0.00649	CbGpPWpGaD
Spironolactone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—sarcoma	0.000311	0.00632	CbGpPWpGaD
Spironolactone—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000305	0.0062	CbGpPWpGaD
Spironolactone—Feeling abnormal—Epirubicin—sarcoma	0.000305	0.00214	CcSEcCtD
Spironolactone—Somnolence—Doxorubicin—sarcoma	0.000304	0.00214	CcSEcCtD
Spironolactone—AR—FOXA1 transcription factor network—JUN—sarcoma	0.000302	0.00615	CbGpPWpGaD
Spironolactone—AR—Regulation of Androgen receptor activity—MDM2—sarcoma	0.0003	0.00609	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—FUS—sarcoma	0.000298	0.00605	CbGpPWpGaD
Spironolactone—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000296	0.00208	CcSEcCtD
Spironolactone—PGR—Validated nuclear estrogen receptor alpha network—CCND1—sarcoma	0.000295	0.00599	CbGpPWpGaD
Spironolactone—PGR—Validated nuclear estrogen receptor alpha network—JUN—sarcoma	0.000294	0.00598	CbGpPWpGaD
Spironolactone—Urticaria—Epirubicin—sarcoma	0.000294	0.00207	CcSEcCtD
Spironolactone—Body temperature increased—Epirubicin—sarcoma	0.000292	0.00206	CcSEcCtD
Spironolactone—AR—Integrated Breast Cancer Pathway—ATF1—sarcoma	0.000289	0.00588	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—FOXO1—sarcoma	0.000282	0.00574	CbGpPWpGaD
Spironolactone—Feeling abnormal—Doxorubicin—sarcoma	0.000282	0.00198	CcSEcCtD
Spironolactone—PGR—Signaling by ERBB4—PDGFRB—sarcoma	0.000282	0.00573	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—PDGFRA—sarcoma	0.000277	0.00564	CbGpPWpGaD
Spironolactone—ABCB1—lymph node—sarcoma	0.000273	0.00188	CbGeAlD
Spironolactone—Hypersensitivity—Epirubicin—sarcoma	0.000273	0.00192	CcSEcCtD
Spironolactone—Urticaria—Doxorubicin—sarcoma	0.000272	0.00191	CcSEcCtD
Spironolactone—Body temperature increased—Doxorubicin—sarcoma	0.000271	0.0019	CcSEcCtD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO1—sarcoma	0.00027	0.00549	CbGpPWpGaD
Spironolactone—NR3C1—Circadian Clock—CREB1—sarcoma	0.000267	0.00543	CbGpPWpGaD
Spironolactone—Pruritus—Epirubicin—sarcoma	0.000262	0.00184	CcSEcCtD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—IL2—sarcoma	0.000262	0.00532	CbGpPWpGaD
Spironolactone—AR—Regulation of Androgen receptor activity—JUN—sarcoma	0.000261	0.0053	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—CREB1—sarcoma	0.000258	0.00525	CbGpPWpGaD
Spironolactone—Diarrhoea—Epirubicin—sarcoma	0.000253	0.00178	CcSEcCtD
Spironolactone—AR—Nongenotropic Androgen signaling—HRAS—sarcoma	0.000253	0.00514	CbGpPWpGaD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—CTNNB1—sarcoma	0.000253	0.00513	CbGpPWpGaD
Spironolactone—Hypersensitivity—Doxorubicin—sarcoma	0.000252	0.00177	CcSEcCtD
Spironolactone—Dizziness—Epirubicin—sarcoma	0.000245	0.00172	CcSEcCtD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—sarcoma	0.000243	0.00493	CbGpPWpGaD
Spironolactone—Pruritus—Doxorubicin—sarcoma	0.000242	0.0017	CcSEcCtD
Spironolactone—AR—Androgen receptor signaling pathway—CREB1—sarcoma	0.000239	0.00487	CbGpPWpGaD
Spironolactone—PGR—Validated nuclear estrogen receptor alpha network—MYC—sarcoma	0.000236	0.00481	CbGpPWpGaD
Spironolactone—Vomiting—Epirubicin—sarcoma	0.000235	0.00165	CcSEcCtD
Spironolactone—Diarrhoea—Doxorubicin—sarcoma	0.000234	0.00165	CcSEcCtD
Spironolactone—AR—Regulation of Androgen receptor activity—SRC—sarcoma	0.000234	0.00475	CbGpPWpGaD
Spironolactone—AR—Coregulation of Androgen receptor activity—CCND1—sarcoma	0.000233	0.00474	CbGpPWpGaD
Spironolactone—Rash—Epirubicin—sarcoma	0.000233	0.00164	CcSEcCtD
Spironolactone—Dermatitis—Epirubicin—sarcoma	0.000233	0.00164	CcSEcCtD
Spironolactone—Headache—Epirubicin—sarcoma	0.000232	0.00163	CcSEcCtD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—CXCR4—sarcoma	0.000231	0.0047	CbGpPWpGaD
Spironolactone—AR—Coregulation of Androgen receptor activity—CTNNB1—sarcoma	0.000231	0.0047	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of Androgen receptor activity—MDM2—sarcoma	0.000227	0.00462	CbGpPWpGaD
Spironolactone—Dizziness—Doxorubicin—sarcoma	0.000226	0.00159	CcSEcCtD
Spironolactone—NR3C1—AP-1 transcription factor network—CREB1—sarcoma	0.00022	0.00447	CbGpPWpGaD
Spironolactone—Nausea—Epirubicin—sarcoma	0.00022	0.00154	CcSEcCtD
Spironolactone—Vomiting—Doxorubicin—sarcoma	0.000218	0.00153	CcSEcCtD
Spironolactone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	0.000216	0.0044	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—FOXO1—sarcoma	0.000216	0.00439	CbGpPWpGaD
Spironolactone—Rash—Doxorubicin—sarcoma	0.000216	0.00152	CcSEcCtD
Spironolactone—Dermatitis—Doxorubicin—sarcoma	0.000216	0.00152	CcSEcCtD
Spironolactone—PGR—Signaling by ERBB4—KIT—sarcoma	0.000215	0.00437	CbGpPWpGaD
Spironolactone—Headache—Doxorubicin—sarcoma	0.000214	0.00151	CcSEcCtD
Spironolactone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	0.000213	0.00433	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—CREB1—sarcoma	0.000205	0.00416	CbGpPWpGaD
Spironolactone—Nausea—Doxorubicin—sarcoma	0.000203	0.00143	CcSEcCtD
Spironolactone—AR—Androgen receptor signaling pathway—MDM2—sarcoma	0.000198	0.00403	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of Androgen receptor activity—JUN—sarcoma	0.000198	0.00402	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREB1—sarcoma	0.000196	0.00398	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—CREB1—sarcoma	0.000194	0.00394	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—sarcoma	0.000188	0.00382	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—sarcoma	0.000187	0.00381	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—sarcoma	0.000186	0.00378	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—JUN—sarcoma	0.000186	0.00377	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—FOXO1—sarcoma	0.000185	0.00376	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—FUS—sarcoma	0.000181	0.00369	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of Androgen receptor activity—SRC—sarcoma	0.000177	0.0036	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	0.000176	0.00358	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—CCND1—sarcoma	0.000173	0.00351	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—JUN—sarcoma	0.000172	0.0035	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—CTNNB1—sarcoma	0.000171	0.00347	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—MDM2—sarcoma	0.000169	0.00344	CbGpPWpGaD
Spironolactone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	0.000165	0.00336	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—IL2—sarcoma	0.000163	0.00331	CbGpPWpGaD
Spironolactone—NR3C1—Endoderm Differentiation—CTNNB1—sarcoma	0.000161	0.00327	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—sarcoma	0.00016	0.00326	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—CCND1—sarcoma	0.000159	0.00322	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—JUN—sarcoma	0.000158	0.00322	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—CTNNB1—sarcoma	0.000157	0.00319	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—CREB1—sarcoma	0.000157	0.00319	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—SRC—sarcoma	0.000154	0.00314	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—CREB1—sarcoma	0.000153	0.00311	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—sarcoma	0.000151	0.00306	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—sarcoma	0.000149	0.00303	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—PDGFRA—sarcoma	0.000145	0.00296	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—IL2—sarcoma	0.000143	0.00291	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—sarcoma	0.000141	0.00286	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—JUN—sarcoma	0.000139	0.00283	CbGpPWpGaD
Spironolactone—AR—Gene Expression—FUS—sarcoma	0.000138	0.00281	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—EGFR—sarcoma	0.000135	0.00275	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.000135	0.00275	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—CREB1—sarcoma	0.000134	0.00273	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	0.00013	0.00264	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—MDM2—sarcoma	0.00013	0.00264	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—MYC—sarcoma	0.000127	0.00259	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—NRAS—sarcoma	0.000127	0.00258	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—CREB1—sarcoma	0.000124	0.00252	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—CREB1—sarcoma	0.000116	0.00236	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—EGFR—sarcoma	0.000116	0.00235	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—sarcoma	0.000113	0.0023	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—CCND1—sarcoma	0.000113	0.0023	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—JUN—sarcoma	0.000113	0.00229	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	0.000112	0.00227	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—JUN—sarcoma	0.00011	0.00223	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—KRAS—sarcoma	0.000109	0.00222	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.000109	0.00222	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	0.000108	0.00219	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—FUS—sarcoma	0.000105	0.00213	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—TP53—sarcoma	0.000104	0.00212	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—VEGFA—sarcoma	9.85e-05	0.002	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—ENO2—sarcoma	9.75e-05	0.00198	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—HBA1—sarcoma	9.69e-05	0.00197	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—VEGFA—sarcoma	9.6e-05	0.00195	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—CTNNB1—sarcoma	9.57e-05	0.00195	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	9.36e-05	0.0019	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	9.35e-05	0.0019	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—HRAS—sarcoma	9.3e-05	0.00189	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	9.27e-05	0.00189	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—TP53—sarcoma	9.21e-05	0.00187	CbGpPWpGaD
Spironolactone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	9.09e-05	0.00185	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—MYC—sarcoma	9.07e-05	0.00184	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—JUN—sarcoma	8.91e-05	0.00181	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—EGFR—sarcoma	8.87e-05	0.0018	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ENO2—sarcoma	8.4e-05	0.00171	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	8.38e-05	0.0017	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—KRAS—sarcoma	8.38e-05	0.0017	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—HBA1—sarcoma	8.35e-05	0.0017	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—JUN—sarcoma	8.34e-05	0.00169	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PLCG1—sarcoma	8.27e-05	0.00168	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—sarcoma	8.27e-05	0.00168	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	8.16e-05	0.00166	CbGpPWpGaD
Spironolactone—NR3C2—Generic Transcription Pathway—MYC—sarcoma	8.04e-05	0.00163	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—IL2—sarcoma	7.93e-05	0.00161	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—sarcoma	7.79e-05	0.00158	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TLE1—sarcoma	7.77e-05	0.00158	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	7.51e-05	0.00153	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—TP53—sarcoma	7.44e-05	0.00151	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	7.35e-05	0.00149	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—VEGFA—sarcoma	7.28e-05	0.00148	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	7.18e-05	0.00146	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PLCG1—sarcoma	7.13e-05	0.00145	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	6.94e-05	0.00141	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—VEGFA—sarcoma	6.74e-05	0.00137	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—VEGFC—sarcoma	6.56e-05	0.00133	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	6.17e-05	0.00125	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	5.3e-05	0.00108	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ENO2—sarcoma	5.27e-05	0.00107	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—FLT1—sarcoma	5.24e-05	0.00107	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—HBA1—sarcoma	5.24e-05	0.00106	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PLCG1—sarcoma	5.15e-05	0.00105	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CXCR4—sarcoma	4.95e-05	0.00101	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—MYC—sarcoma	4.9e-05	0.000995	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ATF1—sarcoma	4.9e-05	0.000995	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PLCG1—sarcoma	4.47e-05	0.000909	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	4.38e-05	0.000891	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—MYC—sarcoma	3.87e-05	0.000787	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IGF1R—sarcoma	3.84e-05	0.000781	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	3.82e-05	0.000776	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	3.81e-05	0.000774	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	3.78e-05	0.000768	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—MYC—sarcoma	3.73e-05	0.000758	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—FOXO1—sarcoma	3.66e-05	0.000743	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PDGFRB—sarcoma	3.65e-05	0.000742	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PDGFRA—sarcoma	3.59e-05	0.00073	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	3.42e-05	0.000694	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	3.33e-05	0.000676	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	3.06e-05	0.000622	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KDR—sarcoma	3.02e-05	0.000615	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	2.99e-05	0.000609	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—MYC—sarcoma	2.83e-05	0.000575	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	2.83e-05	0.000575	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KIT—sarcoma	2.79e-05	0.000566	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CREB1—sarcoma	2.65e-05	0.000539	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ENO2—sarcoma	2.59e-05	0.000526	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—HBA1—sarcoma	2.57e-05	0.000523	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	2.51e-05	0.000511	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—MYC—sarcoma	2.36e-05	0.000479	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ENO2—sarcoma	2.26e-05	0.000458	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HBA1—sarcoma	2.24e-05	0.000456	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PLCG1—sarcoma	2.2e-05	0.000447	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MDM2—sarcoma	2.19e-05	0.000446	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL2—sarcoma	1.96e-05	0.000399	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PLCG1—sarcoma	1.91e-05	0.000389	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCND1—sarcoma	1.91e-05	0.000389	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—JUN—sarcoma	1.91e-05	0.000388	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CTNNB1—sarcoma	1.89e-05	0.000385	CbGpPWpGaD
Spironolactone—AR—Gene Expression—MYC—sarcoma	1.8e-05	0.000365	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SRC—sarcoma	1.71e-05	0.000348	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—VEGFA—sarcoma	1.67e-05	0.000339	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NRAS—sarcoma	1.65e-05	0.000335	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MYC—sarcoma	1.53e-05	0.000312	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EGFR—sarcoma	1.5e-05	0.000305	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KRAS—sarcoma	1.42e-05	0.000288	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—MYC—sarcoma	1.36e-05	0.000277	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TP53—sarcoma	1.26e-05	0.000256	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HRAS—sarcoma	1.2e-05	0.000245	CbGpPWpGaD
